12.07.2015 Views

The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

A <strong>Clinical</strong> <strong>Guide</strong> <strong>to</strong> <strong>Supportive</strong> <strong>and</strong> <strong>Palliative</strong> <strong>Care</strong> <strong>for</strong> <strong>HIV</strong>/<strong>AIDS</strong> • Chapter 9: Derma<strong>to</strong>logic ProblemsDifferential DiagnosisClassical scabies: Insect bite reactions, papular urticaria, drug reaction, folliculitis, prurigosimplex, organic causes of pruritus; crusted scabies: psoriasis, various <strong>for</strong>ms of eczema<strong>and</strong> lichen planus.26 picasDiagnosisIdentification of the mites, their eggs, or their feces from skin scrapings is necessary <strong>for</strong>diagnosis. <strong>The</strong> region most fruitful <strong>for</strong> scraping is a nonexcoriated papule, especially inthe burrows. Scrapings can also be per<strong>for</strong>med from under the fingernails because this is aprotected area. Once an adequate sample is scraped on<strong>to</strong> a microscope slide, a drop ofmineral oil is placed on the specimen <strong>and</strong> covered with a coverslip be<strong>for</strong>e viewing underthe microscope.TreatmentScabetic infestation represents a good example of why <strong>to</strong>pical steroids should not be given<strong>to</strong> patients until an exact diagnosis has been reached. Suppression of the local immuneresponse around the infection will only help the mite, not the patient. Even though theestimated life span of the mite outside of human hosts is very short, it is important that thepatient’s environment, including bed sheets, <strong>to</strong>wels, <strong>and</strong> personal clothing that have beenworn <strong>and</strong> are not freshly laundered should all be washed. Whenever possible, carpeting<strong>and</strong> upholstery should be cleaned. This should be done after the patient has completedthe recommended treatment. In addition, all intimate contacts <strong>and</strong> nonintimate householdor roommate contacts should be treated simultaneously. Health care workers whohad direct skin contact with the patient or their bed should also be treated as soon aspossible. Topical antiscabetic preparations include permethrin 5%, crotami<strong>to</strong>n 10%, <strong>and</strong>lindane 1%, applied <strong>to</strong> cover the entire body surface once, washed off 10 <strong>to</strong> 12 hours later<strong>and</strong> repeated 10 <strong>to</strong> 14 days later when the female mite’s eggs hatch. Ivermectin, althoughnot FDA-approved <strong>for</strong> this purpose, has shown <strong>to</strong> be effective as a single-dose oral treatment<strong>for</strong> scabies in both <strong>HIV</strong>-positive <strong>and</strong> <strong>HIV</strong>-negative individuals. 11 <strong>The</strong> dose is 200 micrograms(µg) per kilogram of body weight once <strong>and</strong> repeated 10 days later if necessary.This is a good option when compliance is questionable <strong>and</strong> in epidemics affecting hospitals<strong>and</strong> hospices. Case reports have noted that <strong>for</strong> the thick plaques of crusted scabies, acombination of oral <strong>and</strong> <strong>to</strong>pical antiscabetic regimens is likely most effective. For cases ofcrusted scabies, a kera<strong>to</strong>lytic agent such as salicylic acid 3–5% or urea 20% should also beused <strong>to</strong> facilitate removal of the crusts that harbor thous<strong>and</strong>s of mites <strong>and</strong> penetration ofthe antiscabetic medication. Side effects of ivermectin include eosinophilia <strong>and</strong> constitutionalsymp<strong>to</strong>ms. It should not be given <strong>to</strong> young children, pregnant women, or breastfeedingmothers.Kaposi’s SarcomaKaposi’s sarcoma (KS) is the most common tumor seen in patients infected with <strong>HIV</strong> <strong>and</strong> isan <strong>AIDS</strong>-defining illness. More common in homosexual or bisexual men, KS is also 300 timesmore common in <strong>AIDS</strong> patients than in patients immunosuppressed <strong>for</strong> transplants. <strong>The</strong> etiologyis clearly multifac<strong>to</strong>rial; however, there have been significant strides made in the past decadein underst<strong>and</strong>ing the pathogenesis of this tumor. At the heart of the pathology is angiogen-196U.S. Department of Health <strong>and</strong> Human Services • Health Resources <strong>and</strong> Services Administration • <strong>HIV</strong>/<strong>AIDS</strong> Bureau

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!